Why Both Mounjaro vs Wegovy Are Popular UK Choices
Mounjaro vs Wegovy: Current UK Stock Availability
The comparison between Mounjaro vs Wegovy often comes down to availability, and we're pleased to confirm both treatments are currently in stock with no supply chain disruptions. Wegovy supply has stabilised significantly since the initial shortages of 2022-2023, with Novo Nordisk ensuring consistent UK distribution through registered pharmacies like EverydayMeds (GPhC #9012878). All five Wegovy doses are available for immediate dispatch, from the 0.25mg starter dose through to the 2.4mg maintenance strength. Mounjaro availability has remained more consistent, with all doses readily accessible for patients whose prescribers recommend tirzepatide over semaglutide.
When evaluating Mounjaro vs Wegovy stock levels, it's worth noting that demand patterns differ between the two treatments. Wegovy's established clinical evidence from the STEP trial programme has created steady demand, whilst Mounjaro's newer market presence means availability fluctuations are less common. Both treatments require the same cold-chain storage and handling protocols, ensuring medication integrity from manufacturer to patient. Our pharmacy maintains robust inventory management for both options, with automated reordering systems preventing stock-outs that have affected other suppliers in the past.
Mounjaro vs Wegovy: UK Pricing and Value Comparison
The cost comparison between Mounjaro vs Wegovy reveals important differences in treatment investment over time. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 discount code), progressing through £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our bundle options provide added convenience, with the Intro Duo (0.25mg and 0.5mg) priced at £169.99, covering the first 8 weeks of treatment. The Progress Trio bundle (0.5mg, 1mg, and 1.7mg) offers 12 weeks of step-up dosing for £369.99, eliminating the need for multiple orders during dose escalation.
Value considerations in the Mounjaro vs Wegovy decision extend beyond unit pricing to include practical factors like storage requirements and dosing flexibility. Wegovy offers a storage advantage with 6 weeks of room temperature stability once removed from refrigeration, compared to Mounjaro's 21-day limit. This makes Wegovy more suitable for patients with travel commitments or variable schedules. Returning customers can apply discount code DOSE25 at checkout, whilst new patients use FIRST40 to access our competitive pricing structure. Both treatments require the same prescriber oversight and clinical monitoring, so ongoing consultation costs remain comparable regardless of your choice in the Mounjaro vs Wegovy decision.
Clinical Evidence: Mounjaro vs Wegovy Research Findings
The clinical evidence supporting both options in the Mounjaro vs Wegovy comparison comes from different but equally rigorous trial programmes. Wegovy's evidence base stems primarily from the STEP clinical trial series, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when used alongside diet and exercise interventions (Wilding et al., NEJM, 2021). The STEP 2 trial showed around clinically studied weight loss in patients with type 2 diabetes, whilst STEP 3 achieved approximately clinically studied weight loss when combined with intensive behavioural therapy.
Mounjaro's clinical programme focuses on the SURMOUNT trials, evaluating tirzepatide's dual GIP and GLP-1 receptor agonist mechanism in weight management contexts. Both treatment approaches have demonstrated cardiovascular benefits, with Wegovy's SELECT trial showing a 20% reduction in major cardiovascular events. When considering Mounjaro vs Wegovy based on clinical evidence, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and patient populations.
How Wegovy Works in the Mounjaro vs Wegovy Comparison
Understanding Wegovy's mechanism helps clarify its role in the Mounjaro vs Wegovy treatment landscape. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a natural hormone released after eating. This medication works primarily on brain appetite centres, particularly in the hypothalamus, to reduce hunger signals and increase feelings of satiety after smaller meals. The once-weekly injection provides sustained hormone levels, helping patients feel satisfied with reduced food intake throughout the week. Many patients report decreased food cravings and reduced preoccupation with eating, though individual responses can vary. The medication's effects on gastric emptying also contribute to prolonged fullness, supporting the reduced-calorie diet that's essential for successful weight management outcomes.
Ordering Process: Mounjaro vs Wegovy at EverydayMeds
The ordering process remains identical whether you choose Mounjaro or Wegovy, ensuring consistent service regardless of your treatment decision. Our 3-minute online clinical assessment covers medical history, current medications, weight management goals, and any previous experience with GLP-1 treatments. Prescriber reviews typically complete within 3 working days, though express 24-hour review is available for urgent requirements. Once approved, both Mounjaro and Wegovy ship via next-day delivery using specialist cold-chain logistics to maintain the 2-8°C temperature requirements. Our pharmacy team coordinates delivery timing to ensure you're available to receive temperature-sensitive medications promptly. The entire process from assessment to delivery typically takes 4-5 days with standard review, or 2-3 days with express service.
Storage and Practical Considerations: Mounjaro vs Wegovy
Practical storage differences represent a key factor in many Mounjaro vs Wegovy decisions, particularly for patients with active lifestyles or travel commitments. Wegovy offers superior room temperature stability, remaining effective for up to 6 weeks once removed from refrigerated storage, provided temperatures don't exceed 30°C. Mounjaro requires return to refrigeration within 21 days of removal, making Wegovy more suitable for extended travel or situations where consistent refrigeration isn't assured. Both treatments use pre-filled injection pens with similar administration techniques, though Wegovy's FlexTouch pen design may feel different from Mounjaro's delivery system. The dose escalation schedule differs between treatments, with Wegovy following a structured 4-week progression through each strength level. Patients typically find the injection process straightforward with either option, though some report preferences for one pen design over another.
Supply Chain Reliability: Mounjaro vs Wegovy Availability Trends
Recent supply chain analysis reveals encouraging trends for both options in the Mounjaro vs Wegovy availability landscape. Wegovy supply has stabilised significantly following the manufacturer's capacity expansion and revised distribution strategy throughout 2023-2024. Novo Nordisk's commitment to UK market supply means registered pharmacies like EverydayMeds can maintain consistent stock levels across all dose strengths. Our direct relationships with pharmaceutical wholesalers provide early visibility of any potential supply constraints, allowing proactive inventory management. Historical data shows Mounjaro availability has remained more predictable, with fewer supply interruptions since its UK launch.
The competitive dynamics between Mounjaro vs Wegovy have actually improved overall market stability, as manufacturers compete on reliability alongside clinical outcomes. Both Eli Lilly (Mounjaro) and Novo Nordisk (Wegovy) have invested heavily in UK manufacturing and distribution capacity to meet growing demand. Our pharmacy maintains safety stock levels for both treatments, typically holding 4-6 weeks of inventory to buffer against unexpected demand spikes. This approach has allowed uninterrupted supply even during periods when other pharmacies experienced temporary shortages.
Making Your Mounjaro vs Wegovy Decision
Your final choice in the Mounjaro vs Wegovy comparison should align with your individual medical profile, lifestyle requirements, and treatment preferences. Both treatments are available from EverydayMeds with comprehensive prescriber support to guide your decision-making process. Consider factors like storage flexibility, dosing schedules, your medical history, and any previous experiences with similar treatments when discussing options with our clinical team. New customers can start their assessment today using discount code FIRST40, with both Mounjaro and Wegovy ready for immediate dispatch once prescribed. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, knowing that whatever choice you make in the Mounjaro vs Wegovy decision, you'll receive expert support from our GPhC-registered pharmacy throughout your weight management journey. Our experienced prescribers will help ensure your chosen treatment integrates effectively with your reduced-calorie diet and increased physical activity programme for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
